ALIMENT PHARM THER 润色咨询

ALIMENTARY PHARMACOLOGY & THERAPEUTICS

出版年份:1987 年文章数:3252 投稿命中率: 开通期刊会员,数据随心看

出版周期:Semimonthly 自引率:9.4% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2122768, encodeId=4ccf2122e6838, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:诊断;消化;肝病<br>经验分享:投稿难度还是比较大的<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=819b5107064, createdName=提奥多拉, createdTime=Thu Mar 30 16:13:17 CST 2023, time=2023-03-30, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2099252, encodeId=839520992525c, content=偏重的研究方向:肝脏疾病;肠道菌群<br>经验分享:中午投稿,晚上状态成Awaiting Reviewer Selection,请问大神这是啥意思?是已经过了编辑那关,准备送外审?还是还在编辑部?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210112/9d391e0b1cd74e869f11d621441146a1/0f85d4b8f25545bc8cd6ff7d737de80d.jpg, createdBy=8aaa108952, createdName=JayNi, createdTime=Tue Nov 08 20:24:51 CST 2022, time=2022-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2101423, encodeId=512e210142384, content=偏重的研究方向:肝病;药物<br>经验分享:今天中午提交的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d0f55424845, createdName=ms7000001723413329, createdTime=Fri Nov 18 22:28:50 CST 2022, time=2022-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1219519, encodeId=594b1219519bd, content=偏重的研究方向:胃肠病;回顾性<br>经验分享:咨询一下,awaiting reviewer selection是什么意思, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9ffb5456603, createdName=ms4000001258378613, createdTime=Sat May 14 09:24:32 CST 2022, time=2022-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1219632, encodeId=c345121963242, content=投稿第二天就成了Awaiting Reviewer Selection状态,连着三天都没有变,是什么情况, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9ffb5456603, createdName=ms4000001258378613, createdTime=Sat May 14 20:03:58 CST 2022, time=2022-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1187960, encodeId=b0b9118e9608c, content=Awaiting Reviewer Selection7天了,IBD的基础研究综述,大家有类似的经历吗?是不是找不到审稿人,还是要被婉拒?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=161, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=62785559987, createdName=ZZLLZZ, createdTime=Tue Jan 25 10:25:06 CST 2022, time=2022-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1207178, encodeId=7ece120e17878, content=大家一般审稿周期多久?投了快20天了,一直是等待审稿人意见。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa635543685, createdName=ms3000001822306968, createdTime=Wed Mar 30 11:26:59 CST 2022, time=2022-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586563, encodeId=05765865636c, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:12月31投了一篇肝病方向的论著,第二天就显示送外审了,很快,半个月左右就显示Awaiting editor decision应该是外审结果回来了,结果一直等到1月31,正好一个月才给结果,外审送了两个审稿人,提了很多小问题,没说同意也没说拒稿,第三个责任编辑亲自审稿,说杂志只接收13%的文章,不符合杂志内容,建议立即改投他们推荐的杂志,查了一下推荐的杂志,An international journal of gastroenterology and hepatology,连ESCI都不是,最后拒绝了,然后就秒拒了 I?therefore?recommend?that?you?consider?submitting?this?paper?immediately?to?the?journal?GastroHep?(https://onlinelibrary.wiley.com/journal/14781239)?–?a?new?Wiley?journal?in?Gastroenterology?and?Hepatology. To?transfer?your?article?and?the?associated?reviews?to?the?GastroHep?ScholarOne?submission?website,?please?click?the?link?below.??A?member?of?the?GastroHep?editorial?office?will?then?be?in?touch. Accept?transfer: ***?PLEASE?NOTE:?This?is?a?two-step?process.?After?clicking?on?the?link,?you?will?be?directed?to?a?webpage?to?confirm.?***? https://mc.manuscriptcentral.com/apt?URL_MASK=bf8646654042460592466ce5f6b01cb5, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=312, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2fd62045489, createdName=1861eaa8b6m, createdTime=Sat Mar 14 00:00:00 CST 2020, time=2020-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1206722, encodeId=dec61206e22e1, content=这个杂志现在还收稿吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=154, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ac9d5484204, createdName=ms4000001196933191, createdTime=Mon Mar 28 21:47:21 CST 2022, time=2022-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197549, encodeId=9b12119e549fb, content=这个杂志的审稿速度咋样???一直是awaiting rewiewer comments??? , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=75835552705, createdName=ms1000001073912817, createdTime=Sat Feb 26 18:32:48 CST 2022, time=2022-02-26, status=1, ipAttribution=)]
    2023-03-30 提奥多拉 来自北京

    审稿速度:1.0 | 投稿命中率:25.0
    偏重的研究方向:诊断;消化;肝病
    经验分享:投稿难度还是比较大的

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2122768, encodeId=4ccf2122e6838, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:诊断;消化;肝病<br>经验分享:投稿难度还是比较大的<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=819b5107064, createdName=提奥多拉, createdTime=Thu Mar 30 16:13:17 CST 2023, time=2023-03-30, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2099252, encodeId=839520992525c, content=偏重的研究方向:肝脏疾病;肠道菌群<br>经验分享:中午投稿,晚上状态成Awaiting Reviewer Selection,请问大神这是啥意思?是已经过了编辑那关,准备送外审?还是还在编辑部?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210112/9d391e0b1cd74e869f11d621441146a1/0f85d4b8f25545bc8cd6ff7d737de80d.jpg, createdBy=8aaa108952, createdName=JayNi, createdTime=Tue Nov 08 20:24:51 CST 2022, time=2022-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2101423, encodeId=512e210142384, content=偏重的研究方向:肝病;药物<br>经验分享:今天中午提交的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d0f55424845, createdName=ms7000001723413329, createdTime=Fri Nov 18 22:28:50 CST 2022, time=2022-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1219519, encodeId=594b1219519bd, content=偏重的研究方向:胃肠病;回顾性<br>经验分享:咨询一下,awaiting reviewer selection是什么意思, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9ffb5456603, createdName=ms4000001258378613, createdTime=Sat May 14 09:24:32 CST 2022, time=2022-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1219632, encodeId=c345121963242, content=投稿第二天就成了Awaiting Reviewer Selection状态,连着三天都没有变,是什么情况, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9ffb5456603, createdName=ms4000001258378613, createdTime=Sat May 14 20:03:58 CST 2022, time=2022-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1187960, encodeId=b0b9118e9608c, content=Awaiting Reviewer Selection7天了,IBD的基础研究综述,大家有类似的经历吗?是不是找不到审稿人,还是要被婉拒?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=161, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=62785559987, createdName=ZZLLZZ, createdTime=Tue Jan 25 10:25:06 CST 2022, time=2022-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1207178, encodeId=7ece120e17878, content=大家一般审稿周期多久?投了快20天了,一直是等待审稿人意见。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa635543685, createdName=ms3000001822306968, createdTime=Wed Mar 30 11:26:59 CST 2022, time=2022-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586563, encodeId=05765865636c, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:12月31投了一篇肝病方向的论著,第二天就显示送外审了,很快,半个月左右就显示Awaiting editor decision应该是外审结果回来了,结果一直等到1月31,正好一个月才给结果,外审送了两个审稿人,提了很多小问题,没说同意也没说拒稿,第三个责任编辑亲自审稿,说杂志只接收13%的文章,不符合杂志内容,建议立即改投他们推荐的杂志,查了一下推荐的杂志,An international journal of gastroenterology and hepatology,连ESCI都不是,最后拒绝了,然后就秒拒了 I?therefore?recommend?that?you?consider?submitting?this?paper?immediately?to?the?journal?GastroHep?(https://onlinelibrary.wiley.com/journal/14781239)?–?a?new?Wiley?journal?in?Gastroenterology?and?Hepatology. To?transfer?your?article?and?the?associated?reviews?to?the?GastroHep?ScholarOne?submission?website,?please?click?the?link?below.??A?member?of?the?GastroHep?editorial?office?will?then?be?in?touch. Accept?transfer: ***?PLEASE?NOTE:?This?is?a?two-step?process.?After?clicking?on?the?link,?you?will?be?directed?to?a?webpage?to?confirm.?***? https://mc.manuscriptcentral.com/apt?URL_MASK=bf8646654042460592466ce5f6b01cb5, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=312, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2fd62045489, createdName=1861eaa8b6m, createdTime=Sat Mar 14 00:00:00 CST 2020, time=2020-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1206722, encodeId=dec61206e22e1, content=这个杂志现在还收稿吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=154, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ac9d5484204, createdName=ms4000001196933191, createdTime=Mon Mar 28 21:47:21 CST 2022, time=2022-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197549, encodeId=9b12119e549fb, content=这个杂志的审稿速度咋样???一直是awaiting rewiewer comments??? , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=75835552705, createdName=ms1000001073912817, createdTime=Sat Feb 26 18:32:48 CST 2022, time=2022-02-26, status=1, ipAttribution=)]
    2022-11-08 JayNi

    偏重的研究方向:肝脏疾病;肠道菌群
    经验分享:中午投稿,晚上状态成Awaiting Reviewer Selection,请问大神这是啥意思?是已经过了编辑那关,准备送外审?还是还在编辑部?

    6

    展开6条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=2122768, encodeId=4ccf2122e6838, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:诊断;消化;肝病<br>经验分享:投稿难度还是比较大的<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=819b5107064, createdName=提奥多拉, createdTime=Thu Mar 30 16:13:17 CST 2023, time=2023-03-30, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2099252, encodeId=839520992525c, content=偏重的研究方向:肝脏疾病;肠道菌群<br>经验分享:中午投稿,晚上状态成Awaiting Reviewer Selection,请问大神这是啥意思?是已经过了编辑那关,准备送外审?还是还在编辑部?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210112/9d391e0b1cd74e869f11d621441146a1/0f85d4b8f25545bc8cd6ff7d737de80d.jpg, createdBy=8aaa108952, createdName=JayNi, createdTime=Tue Nov 08 20:24:51 CST 2022, time=2022-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2101423, encodeId=512e210142384, content=偏重的研究方向:肝病;药物<br>经验分享:今天中午提交的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d0f55424845, createdName=ms7000001723413329, createdTime=Fri Nov 18 22:28:50 CST 2022, time=2022-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1219519, encodeId=594b1219519bd, content=偏重的研究方向:胃肠病;回顾性<br>经验分享:咨询一下,awaiting reviewer selection是什么意思, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9ffb5456603, createdName=ms4000001258378613, createdTime=Sat May 14 09:24:32 CST 2022, time=2022-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1219632, encodeId=c345121963242, content=投稿第二天就成了Awaiting Reviewer Selection状态,连着三天都没有变,是什么情况, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9ffb5456603, createdName=ms4000001258378613, createdTime=Sat May 14 20:03:58 CST 2022, time=2022-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1187960, encodeId=b0b9118e9608c, content=Awaiting Reviewer Selection7天了,IBD的基础研究综述,大家有类似的经历吗?是不是找不到审稿人,还是要被婉拒?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=161, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=62785559987, createdName=ZZLLZZ, createdTime=Tue Jan 25 10:25:06 CST 2022, time=2022-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1207178, encodeId=7ece120e17878, content=大家一般审稿周期多久?投了快20天了,一直是等待审稿人意见。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa635543685, createdName=ms3000001822306968, createdTime=Wed Mar 30 11:26:59 CST 2022, time=2022-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586563, encodeId=05765865636c, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:12月31投了一篇肝病方向的论著,第二天就显示送外审了,很快,半个月左右就显示Awaiting editor decision应该是外审结果回来了,结果一直等到1月31,正好一个月才给结果,外审送了两个审稿人,提了很多小问题,没说同意也没说拒稿,第三个责任编辑亲自审稿,说杂志只接收13%的文章,不符合杂志内容,建议立即改投他们推荐的杂志,查了一下推荐的杂志,An international journal of gastroenterology and hepatology,连ESCI都不是,最后拒绝了,然后就秒拒了 I?therefore?recommend?that?you?consider?submitting?this?paper?immediately?to?the?journal?GastroHep?(https://onlinelibrary.wiley.com/journal/14781239)?–?a?new?Wiley?journal?in?Gastroenterology?and?Hepatology. To?transfer?your?article?and?the?associated?reviews?to?the?GastroHep?ScholarOne?submission?website,?please?click?the?link?below.??A?member?of?the?GastroHep?editorial?office?will?then?be?in?touch. Accept?transfer: ***?PLEASE?NOTE:?This?is?a?two-step?process.?After?clicking?on?the?link,?you?will?be?directed?to?a?webpage?to?confirm.?***? https://mc.manuscriptcentral.com/apt?URL_MASK=bf8646654042460592466ce5f6b01cb5, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=312, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2fd62045489, createdName=1861eaa8b6m, createdTime=Sat Mar 14 00:00:00 CST 2020, time=2020-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1206722, encodeId=dec61206e22e1, content=这个杂志现在还收稿吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=154, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ac9d5484204, createdName=ms4000001196933191, createdTime=Mon Mar 28 21:47:21 CST 2022, time=2022-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197549, encodeId=9b12119e549fb, content=这个杂志的审稿速度咋样???一直是awaiting rewiewer comments??? , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=75835552705, createdName=ms1000001073912817, createdTime=Sat Feb 26 18:32:48 CST 2022, time=2022-02-26, status=1, ipAttribution=)]
    2022-11-18 ms7000001723413329

    偏重的研究方向:肝病;药物
    经验分享:今天中午提交的

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2122768, encodeId=4ccf2122e6838, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:诊断;消化;肝病<br>经验分享:投稿难度还是比较大的<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=819b5107064, createdName=提奥多拉, createdTime=Thu Mar 30 16:13:17 CST 2023, time=2023-03-30, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2099252, encodeId=839520992525c, content=偏重的研究方向:肝脏疾病;肠道菌群<br>经验分享:中午投稿,晚上状态成Awaiting Reviewer Selection,请问大神这是啥意思?是已经过了编辑那关,准备送外审?还是还在编辑部?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210112/9d391e0b1cd74e869f11d621441146a1/0f85d4b8f25545bc8cd6ff7d737de80d.jpg, createdBy=8aaa108952, createdName=JayNi, createdTime=Tue Nov 08 20:24:51 CST 2022, time=2022-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2101423, encodeId=512e210142384, content=偏重的研究方向:肝病;药物<br>经验分享:今天中午提交的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d0f55424845, createdName=ms7000001723413329, createdTime=Fri Nov 18 22:28:50 CST 2022, time=2022-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1219519, encodeId=594b1219519bd, content=偏重的研究方向:胃肠病;回顾性<br>经验分享:咨询一下,awaiting reviewer selection是什么意思, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9ffb5456603, createdName=ms4000001258378613, createdTime=Sat May 14 09:24:32 CST 2022, time=2022-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1219632, encodeId=c345121963242, content=投稿第二天就成了Awaiting Reviewer Selection状态,连着三天都没有变,是什么情况, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9ffb5456603, createdName=ms4000001258378613, createdTime=Sat May 14 20:03:58 CST 2022, time=2022-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1187960, encodeId=b0b9118e9608c, content=Awaiting Reviewer Selection7天了,IBD的基础研究综述,大家有类似的经历吗?是不是找不到审稿人,还是要被婉拒?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=161, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=62785559987, createdName=ZZLLZZ, createdTime=Tue Jan 25 10:25:06 CST 2022, time=2022-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1207178, encodeId=7ece120e17878, content=大家一般审稿周期多久?投了快20天了,一直是等待审稿人意见。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa635543685, createdName=ms3000001822306968, createdTime=Wed Mar 30 11:26:59 CST 2022, time=2022-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586563, encodeId=05765865636c, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:12月31投了一篇肝病方向的论著,第二天就显示送外审了,很快,半个月左右就显示Awaiting editor decision应该是外审结果回来了,结果一直等到1月31,正好一个月才给结果,外审送了两个审稿人,提了很多小问题,没说同意也没说拒稿,第三个责任编辑亲自审稿,说杂志只接收13%的文章,不符合杂志内容,建议立即改投他们推荐的杂志,查了一下推荐的杂志,An international journal of gastroenterology and hepatology,连ESCI都不是,最后拒绝了,然后就秒拒了 I?therefore?recommend?that?you?consider?submitting?this?paper?immediately?to?the?journal?GastroHep?(https://onlinelibrary.wiley.com/journal/14781239)?–?a?new?Wiley?journal?in?Gastroenterology?and?Hepatology. To?transfer?your?article?and?the?associated?reviews?to?the?GastroHep?ScholarOne?submission?website,?please?click?the?link?below.??A?member?of?the?GastroHep?editorial?office?will?then?be?in?touch. Accept?transfer: ***?PLEASE?NOTE:?This?is?a?two-step?process.?After?clicking?on?the?link,?you?will?be?directed?to?a?webpage?to?confirm.?***? https://mc.manuscriptcentral.com/apt?URL_MASK=bf8646654042460592466ce5f6b01cb5, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=312, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2fd62045489, createdName=1861eaa8b6m, createdTime=Sat Mar 14 00:00:00 CST 2020, time=2020-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1206722, encodeId=dec61206e22e1, content=这个杂志现在还收稿吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=154, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ac9d5484204, createdName=ms4000001196933191, createdTime=Mon Mar 28 21:47:21 CST 2022, time=2022-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197549, encodeId=9b12119e549fb, content=这个杂志的审稿速度咋样???一直是awaiting rewiewer comments??? , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=75835552705, createdName=ms1000001073912817, createdTime=Sat Feb 26 18:32:48 CST 2022, time=2022-02-26, status=1, ipAttribution=)]
    2022-05-14 ms4000001258378613

    偏重的研究方向:胃肠病;回顾性
    经验分享:咨询一下,awaiting reviewer selection是什么意思

    3

    展开3条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=2122768, encodeId=4ccf2122e6838, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:诊断;消化;肝病<br>经验分享:投稿难度还是比较大的<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=819b5107064, createdName=提奥多拉, createdTime=Thu Mar 30 16:13:17 CST 2023, time=2023-03-30, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2099252, encodeId=839520992525c, content=偏重的研究方向:肝脏疾病;肠道菌群<br>经验分享:中午投稿,晚上状态成Awaiting Reviewer Selection,请问大神这是啥意思?是已经过了编辑那关,准备送外审?还是还在编辑部?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210112/9d391e0b1cd74e869f11d621441146a1/0f85d4b8f25545bc8cd6ff7d737de80d.jpg, createdBy=8aaa108952, createdName=JayNi, createdTime=Tue Nov 08 20:24:51 CST 2022, time=2022-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2101423, encodeId=512e210142384, content=偏重的研究方向:肝病;药物<br>经验分享:今天中午提交的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d0f55424845, createdName=ms7000001723413329, createdTime=Fri Nov 18 22:28:50 CST 2022, time=2022-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1219519, encodeId=594b1219519bd, content=偏重的研究方向:胃肠病;回顾性<br>经验分享:咨询一下,awaiting reviewer selection是什么意思, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9ffb5456603, createdName=ms4000001258378613, createdTime=Sat May 14 09:24:32 CST 2022, time=2022-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1219632, encodeId=c345121963242, content=投稿第二天就成了Awaiting Reviewer Selection状态,连着三天都没有变,是什么情况, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9ffb5456603, createdName=ms4000001258378613, createdTime=Sat May 14 20:03:58 CST 2022, time=2022-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1187960, encodeId=b0b9118e9608c, content=Awaiting Reviewer Selection7天了,IBD的基础研究综述,大家有类似的经历吗?是不是找不到审稿人,还是要被婉拒?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=161, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=62785559987, createdName=ZZLLZZ, createdTime=Tue Jan 25 10:25:06 CST 2022, time=2022-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1207178, encodeId=7ece120e17878, content=大家一般审稿周期多久?投了快20天了,一直是等待审稿人意见。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa635543685, createdName=ms3000001822306968, createdTime=Wed Mar 30 11:26:59 CST 2022, time=2022-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586563, encodeId=05765865636c, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:12月31投了一篇肝病方向的论著,第二天就显示送外审了,很快,半个月左右就显示Awaiting editor decision应该是外审结果回来了,结果一直等到1月31,正好一个月才给结果,外审送了两个审稿人,提了很多小问题,没说同意也没说拒稿,第三个责任编辑亲自审稿,说杂志只接收13%的文章,不符合杂志内容,建议立即改投他们推荐的杂志,查了一下推荐的杂志,An international journal of gastroenterology and hepatology,连ESCI都不是,最后拒绝了,然后就秒拒了 I?therefore?recommend?that?you?consider?submitting?this?paper?immediately?to?the?journal?GastroHep?(https://onlinelibrary.wiley.com/journal/14781239)?–?a?new?Wiley?journal?in?Gastroenterology?and?Hepatology. To?transfer?your?article?and?the?associated?reviews?to?the?GastroHep?ScholarOne?submission?website,?please?click?the?link?below.??A?member?of?the?GastroHep?editorial?office?will?then?be?in?touch. Accept?transfer: ***?PLEASE?NOTE:?This?is?a?two-step?process.?After?clicking?on?the?link,?you?will?be?directed?to?a?webpage?to?confirm.?***? https://mc.manuscriptcentral.com/apt?URL_MASK=bf8646654042460592466ce5f6b01cb5, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=312, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2fd62045489, createdName=1861eaa8b6m, createdTime=Sat Mar 14 00:00:00 CST 2020, time=2020-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1206722, encodeId=dec61206e22e1, content=这个杂志现在还收稿吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=154, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ac9d5484204, createdName=ms4000001196933191, createdTime=Mon Mar 28 21:47:21 CST 2022, time=2022-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197549, encodeId=9b12119e549fb, content=这个杂志的审稿速度咋样???一直是awaiting rewiewer comments??? , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=75835552705, createdName=ms1000001073912817, createdTime=Sat Feb 26 18:32:48 CST 2022, time=2022-02-26, status=1, ipAttribution=)]
    2022-05-14 ms4000001258378613

    投稿第二天就成了Awaiting Reviewer Selection状态,连着三天都没有变,是什么情况

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=2122768, encodeId=4ccf2122e6838, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:诊断;消化;肝病<br>经验分享:投稿难度还是比较大的<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=819b5107064, createdName=提奥多拉, createdTime=Thu Mar 30 16:13:17 CST 2023, time=2023-03-30, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2099252, encodeId=839520992525c, content=偏重的研究方向:肝脏疾病;肠道菌群<br>经验分享:中午投稿,晚上状态成Awaiting Reviewer Selection,请问大神这是啥意思?是已经过了编辑那关,准备送外审?还是还在编辑部?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210112/9d391e0b1cd74e869f11d621441146a1/0f85d4b8f25545bc8cd6ff7d737de80d.jpg, createdBy=8aaa108952, createdName=JayNi, createdTime=Tue Nov 08 20:24:51 CST 2022, time=2022-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2101423, encodeId=512e210142384, content=偏重的研究方向:肝病;药物<br>经验分享:今天中午提交的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d0f55424845, createdName=ms7000001723413329, createdTime=Fri Nov 18 22:28:50 CST 2022, time=2022-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1219519, encodeId=594b1219519bd, content=偏重的研究方向:胃肠病;回顾性<br>经验分享:咨询一下,awaiting reviewer selection是什么意思, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9ffb5456603, createdName=ms4000001258378613, createdTime=Sat May 14 09:24:32 CST 2022, time=2022-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1219632, encodeId=c345121963242, content=投稿第二天就成了Awaiting Reviewer Selection状态,连着三天都没有变,是什么情况, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9ffb5456603, createdName=ms4000001258378613, createdTime=Sat May 14 20:03:58 CST 2022, time=2022-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1187960, encodeId=b0b9118e9608c, content=Awaiting Reviewer Selection7天了,IBD的基础研究综述,大家有类似的经历吗?是不是找不到审稿人,还是要被婉拒?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=161, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=62785559987, createdName=ZZLLZZ, createdTime=Tue Jan 25 10:25:06 CST 2022, time=2022-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1207178, encodeId=7ece120e17878, content=大家一般审稿周期多久?投了快20天了,一直是等待审稿人意见。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa635543685, createdName=ms3000001822306968, createdTime=Wed Mar 30 11:26:59 CST 2022, time=2022-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586563, encodeId=05765865636c, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:12月31投了一篇肝病方向的论著,第二天就显示送外审了,很快,半个月左右就显示Awaiting editor decision应该是外审结果回来了,结果一直等到1月31,正好一个月才给结果,外审送了两个审稿人,提了很多小问题,没说同意也没说拒稿,第三个责任编辑亲自审稿,说杂志只接收13%的文章,不符合杂志内容,建议立即改投他们推荐的杂志,查了一下推荐的杂志,An international journal of gastroenterology and hepatology,连ESCI都不是,最后拒绝了,然后就秒拒了 I?therefore?recommend?that?you?consider?submitting?this?paper?immediately?to?the?journal?GastroHep?(https://onlinelibrary.wiley.com/journal/14781239)?–?a?new?Wiley?journal?in?Gastroenterology?and?Hepatology. To?transfer?your?article?and?the?associated?reviews?to?the?GastroHep?ScholarOne?submission?website,?please?click?the?link?below.??A?member?of?the?GastroHep?editorial?office?will?then?be?in?touch. Accept?transfer: ***?PLEASE?NOTE:?This?is?a?two-step?process.?After?clicking?on?the?link,?you?will?be?directed?to?a?webpage?to?confirm.?***? https://mc.manuscriptcentral.com/apt?URL_MASK=bf8646654042460592466ce5f6b01cb5, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=312, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2fd62045489, createdName=1861eaa8b6m, createdTime=Sat Mar 14 00:00:00 CST 2020, time=2020-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1206722, encodeId=dec61206e22e1, content=这个杂志现在还收稿吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=154, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ac9d5484204, createdName=ms4000001196933191, createdTime=Mon Mar 28 21:47:21 CST 2022, time=2022-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197549, encodeId=9b12119e549fb, content=这个杂志的审稿速度咋样???一直是awaiting rewiewer comments??? , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=75835552705, createdName=ms1000001073912817, createdTime=Sat Feb 26 18:32:48 CST 2022, time=2022-02-26, status=1, ipAttribution=)]
    2022-01-25 ZZLLZZ

    Awaiting Reviewer Selection7天了,IBD的基础研究综述,大家有类似的经历吗?是不是找不到审稿人,还是要被婉拒?

    1

    展开1条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=2122768, encodeId=4ccf2122e6838, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:诊断;消化;肝病<br>经验分享:投稿难度还是比较大的<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=819b5107064, createdName=提奥多拉, createdTime=Thu Mar 30 16:13:17 CST 2023, time=2023-03-30, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2099252, encodeId=839520992525c, content=偏重的研究方向:肝脏疾病;肠道菌群<br>经验分享:中午投稿,晚上状态成Awaiting Reviewer Selection,请问大神这是啥意思?是已经过了编辑那关,准备送外审?还是还在编辑部?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210112/9d391e0b1cd74e869f11d621441146a1/0f85d4b8f25545bc8cd6ff7d737de80d.jpg, createdBy=8aaa108952, createdName=JayNi, createdTime=Tue Nov 08 20:24:51 CST 2022, time=2022-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2101423, encodeId=512e210142384, content=偏重的研究方向:肝病;药物<br>经验分享:今天中午提交的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d0f55424845, createdName=ms7000001723413329, createdTime=Fri Nov 18 22:28:50 CST 2022, time=2022-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1219519, encodeId=594b1219519bd, content=偏重的研究方向:胃肠病;回顾性<br>经验分享:咨询一下,awaiting reviewer selection是什么意思, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9ffb5456603, createdName=ms4000001258378613, createdTime=Sat May 14 09:24:32 CST 2022, time=2022-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1219632, encodeId=c345121963242, content=投稿第二天就成了Awaiting Reviewer Selection状态,连着三天都没有变,是什么情况, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9ffb5456603, createdName=ms4000001258378613, createdTime=Sat May 14 20:03:58 CST 2022, time=2022-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1187960, encodeId=b0b9118e9608c, content=Awaiting Reviewer Selection7天了,IBD的基础研究综述,大家有类似的经历吗?是不是找不到审稿人,还是要被婉拒?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=161, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=62785559987, createdName=ZZLLZZ, createdTime=Tue Jan 25 10:25:06 CST 2022, time=2022-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1207178, encodeId=7ece120e17878, content=大家一般审稿周期多久?投了快20天了,一直是等待审稿人意见。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa635543685, createdName=ms3000001822306968, createdTime=Wed Mar 30 11:26:59 CST 2022, time=2022-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586563, encodeId=05765865636c, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:12月31投了一篇肝病方向的论著,第二天就显示送外审了,很快,半个月左右就显示Awaiting editor decision应该是外审结果回来了,结果一直等到1月31,正好一个月才给结果,外审送了两个审稿人,提了很多小问题,没说同意也没说拒稿,第三个责任编辑亲自审稿,说杂志只接收13%的文章,不符合杂志内容,建议立即改投他们推荐的杂志,查了一下推荐的杂志,An international journal of gastroenterology and hepatology,连ESCI都不是,最后拒绝了,然后就秒拒了 I?therefore?recommend?that?you?consider?submitting?this?paper?immediately?to?the?journal?GastroHep?(https://onlinelibrary.wiley.com/journal/14781239)?–?a?new?Wiley?journal?in?Gastroenterology?and?Hepatology. To?transfer?your?article?and?the?associated?reviews?to?the?GastroHep?ScholarOne?submission?website,?please?click?the?link?below.??A?member?of?the?GastroHep?editorial?office?will?then?be?in?touch. Accept?transfer: ***?PLEASE?NOTE:?This?is?a?two-step?process.?After?clicking?on?the?link,?you?will?be?directed?to?a?webpage?to?confirm.?***? https://mc.manuscriptcentral.com/apt?URL_MASK=bf8646654042460592466ce5f6b01cb5, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=312, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2fd62045489, createdName=1861eaa8b6m, createdTime=Sat Mar 14 00:00:00 CST 2020, time=2020-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1206722, encodeId=dec61206e22e1, content=这个杂志现在还收稿吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=154, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ac9d5484204, createdName=ms4000001196933191, createdTime=Mon Mar 28 21:47:21 CST 2022, time=2022-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197549, encodeId=9b12119e549fb, content=这个杂志的审稿速度咋样???一直是awaiting rewiewer comments??? , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=75835552705, createdName=ms1000001073912817, createdTime=Sat Feb 26 18:32:48 CST 2022, time=2022-02-26, status=1, ipAttribution=)]
    2022-03-30 ms3000001822306968

    大家一般审稿周期多久?投了快20天了,一直是等待审稿人意见。

    1

    展开1条回复
  8. [GetPortalCommentsPageByObjectIdResponse(id=2122768, encodeId=4ccf2122e6838, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:诊断;消化;肝病<br>经验分享:投稿难度还是比较大的<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=819b5107064, createdName=提奥多拉, createdTime=Thu Mar 30 16:13:17 CST 2023, time=2023-03-30, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2099252, encodeId=839520992525c, content=偏重的研究方向:肝脏疾病;肠道菌群<br>经验分享:中午投稿,晚上状态成Awaiting Reviewer Selection,请问大神这是啥意思?是已经过了编辑那关,准备送外审?还是还在编辑部?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210112/9d391e0b1cd74e869f11d621441146a1/0f85d4b8f25545bc8cd6ff7d737de80d.jpg, createdBy=8aaa108952, createdName=JayNi, createdTime=Tue Nov 08 20:24:51 CST 2022, time=2022-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2101423, encodeId=512e210142384, content=偏重的研究方向:肝病;药物<br>经验分享:今天中午提交的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d0f55424845, createdName=ms7000001723413329, createdTime=Fri Nov 18 22:28:50 CST 2022, time=2022-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1219519, encodeId=594b1219519bd, content=偏重的研究方向:胃肠病;回顾性<br>经验分享:咨询一下,awaiting reviewer selection是什么意思, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9ffb5456603, createdName=ms4000001258378613, createdTime=Sat May 14 09:24:32 CST 2022, time=2022-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1219632, encodeId=c345121963242, content=投稿第二天就成了Awaiting Reviewer Selection状态,连着三天都没有变,是什么情况, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9ffb5456603, createdName=ms4000001258378613, createdTime=Sat May 14 20:03:58 CST 2022, time=2022-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1187960, encodeId=b0b9118e9608c, content=Awaiting Reviewer Selection7天了,IBD的基础研究综述,大家有类似的经历吗?是不是找不到审稿人,还是要被婉拒?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=161, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=62785559987, createdName=ZZLLZZ, createdTime=Tue Jan 25 10:25:06 CST 2022, time=2022-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1207178, encodeId=7ece120e17878, content=大家一般审稿周期多久?投了快20天了,一直是等待审稿人意见。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa635543685, createdName=ms3000001822306968, createdTime=Wed Mar 30 11:26:59 CST 2022, time=2022-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586563, encodeId=05765865636c, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:12月31投了一篇肝病方向的论著,第二天就显示送外审了,很快,半个月左右就显示Awaiting editor decision应该是外审结果回来了,结果一直等到1月31,正好一个月才给结果,外审送了两个审稿人,提了很多小问题,没说同意也没说拒稿,第三个责任编辑亲自审稿,说杂志只接收13%的文章,不符合杂志内容,建议立即改投他们推荐的杂志,查了一下推荐的杂志,An international journal of gastroenterology and hepatology,连ESCI都不是,最后拒绝了,然后就秒拒了 I?therefore?recommend?that?you?consider?submitting?this?paper?immediately?to?the?journal?GastroHep?(https://onlinelibrary.wiley.com/journal/14781239)?–?a?new?Wiley?journal?in?Gastroenterology?and?Hepatology. To?transfer?your?article?and?the?associated?reviews?to?the?GastroHep?ScholarOne?submission?website,?please?click?the?link?below.??A?member?of?the?GastroHep?editorial?office?will?then?be?in?touch. Accept?transfer: ***?PLEASE?NOTE:?This?is?a?two-step?process.?After?clicking?on?the?link,?you?will?be?directed?to?a?webpage?to?confirm.?***? https://mc.manuscriptcentral.com/apt?URL_MASK=bf8646654042460592466ce5f6b01cb5, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=312, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2fd62045489, createdName=1861eaa8b6m, createdTime=Sat Mar 14 00:00:00 CST 2020, time=2020-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1206722, encodeId=dec61206e22e1, content=这个杂志现在还收稿吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=154, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ac9d5484204, createdName=ms4000001196933191, createdTime=Mon Mar 28 21:47:21 CST 2022, time=2022-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197549, encodeId=9b12119e549fb, content=这个杂志的审稿速度咋样???一直是awaiting rewiewer comments??? , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=75835552705, createdName=ms1000001073912817, createdTime=Sat Feb 26 18:32:48 CST 2022, time=2022-02-26, status=1, ipAttribution=)]
    2020-03-14 1861eaa8b6m

    审稿速度:1.0 | 投稿命中率:50.0
    经验分享:12月31投了一篇肝病方向的论著,第二天就显示送外审了,很快,半个月左右就显示Awaiting editor decision应该是外审结果回来了,结果一直等到1月31,正好一个月才给结果,外审送了两个审稿人,提了很多小问题,没说同意也没说拒稿,第三个责任编辑亲自审稿,说杂志只接收13%的文章,不符合杂志内容,建议立即改投他们推荐的杂志,查了一下推荐的杂志,An international journal of gastroenterology and hepatology,连ESCI都不是,最后拒绝了,然后就秒拒了 I?therefore?recommend?that?you?consider?submitting?this?paper?immediately?to?the?journal?GastroHep?(https://onlinelibrary.wiley.com/journal/14781239)?–?a?new?Wiley?journal?in?Gastroenterology?and?Hepatology. To?transfer?your?article?and?the?associated?reviews?to?the?GastroHep?ScholarOne?submission?website,?please?click?the?link?below.??A?member?of?the?GastroHep?editorial?office?will?then?be?in?touch. Accept?transfer: ***?PLEASE?NOTE:?This?is?a?two-step?process.?After?clicking?on?the?link,?you?will?be?directed?to?a?webpage?to?confirm.?***? https://mc.manuscriptcentral.com/apt?URL_MASK=bf8646654042460592466ce5f6b01cb5

    2

    展开2条回复
  9. [GetPortalCommentsPageByObjectIdResponse(id=2122768, encodeId=4ccf2122e6838, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:诊断;消化;肝病<br>经验分享:投稿难度还是比较大的<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=819b5107064, createdName=提奥多拉, createdTime=Thu Mar 30 16:13:17 CST 2023, time=2023-03-30, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2099252, encodeId=839520992525c, content=偏重的研究方向:肝脏疾病;肠道菌群<br>经验分享:中午投稿,晚上状态成Awaiting Reviewer Selection,请问大神这是啥意思?是已经过了编辑那关,准备送外审?还是还在编辑部?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210112/9d391e0b1cd74e869f11d621441146a1/0f85d4b8f25545bc8cd6ff7d737de80d.jpg, createdBy=8aaa108952, createdName=JayNi, createdTime=Tue Nov 08 20:24:51 CST 2022, time=2022-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2101423, encodeId=512e210142384, content=偏重的研究方向:肝病;药物<br>经验分享:今天中午提交的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d0f55424845, createdName=ms7000001723413329, createdTime=Fri Nov 18 22:28:50 CST 2022, time=2022-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1219519, encodeId=594b1219519bd, content=偏重的研究方向:胃肠病;回顾性<br>经验分享:咨询一下,awaiting reviewer selection是什么意思, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9ffb5456603, createdName=ms4000001258378613, createdTime=Sat May 14 09:24:32 CST 2022, time=2022-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1219632, encodeId=c345121963242, content=投稿第二天就成了Awaiting Reviewer Selection状态,连着三天都没有变,是什么情况, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9ffb5456603, createdName=ms4000001258378613, createdTime=Sat May 14 20:03:58 CST 2022, time=2022-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1187960, encodeId=b0b9118e9608c, content=Awaiting Reviewer Selection7天了,IBD的基础研究综述,大家有类似的经历吗?是不是找不到审稿人,还是要被婉拒?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=161, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=62785559987, createdName=ZZLLZZ, createdTime=Tue Jan 25 10:25:06 CST 2022, time=2022-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1207178, encodeId=7ece120e17878, content=大家一般审稿周期多久?投了快20天了,一直是等待审稿人意见。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa635543685, createdName=ms3000001822306968, createdTime=Wed Mar 30 11:26:59 CST 2022, time=2022-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586563, encodeId=05765865636c, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:12月31投了一篇肝病方向的论著,第二天就显示送外审了,很快,半个月左右就显示Awaiting editor decision应该是外审结果回来了,结果一直等到1月31,正好一个月才给结果,外审送了两个审稿人,提了很多小问题,没说同意也没说拒稿,第三个责任编辑亲自审稿,说杂志只接收13%的文章,不符合杂志内容,建议立即改投他们推荐的杂志,查了一下推荐的杂志,An international journal of gastroenterology and hepatology,连ESCI都不是,最后拒绝了,然后就秒拒了 I?therefore?recommend?that?you?consider?submitting?this?paper?immediately?to?the?journal?GastroHep?(https://onlinelibrary.wiley.com/journal/14781239)?–?a?new?Wiley?journal?in?Gastroenterology?and?Hepatology. To?transfer?your?article?and?the?associated?reviews?to?the?GastroHep?ScholarOne?submission?website,?please?click?the?link?below.??A?member?of?the?GastroHep?editorial?office?will?then?be?in?touch. Accept?transfer: ***?PLEASE?NOTE:?This?is?a?two-step?process.?After?clicking?on?the?link,?you?will?be?directed?to?a?webpage?to?confirm.?***? https://mc.manuscriptcentral.com/apt?URL_MASK=bf8646654042460592466ce5f6b01cb5, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=312, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2fd62045489, createdName=1861eaa8b6m, createdTime=Sat Mar 14 00:00:00 CST 2020, time=2020-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1206722, encodeId=dec61206e22e1, content=这个杂志现在还收稿吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=154, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ac9d5484204, createdName=ms4000001196933191, createdTime=Mon Mar 28 21:47:21 CST 2022, time=2022-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197549, encodeId=9b12119e549fb, content=这个杂志的审稿速度咋样???一直是awaiting rewiewer comments??? , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=75835552705, createdName=ms1000001073912817, createdTime=Sat Feb 26 18:32:48 CST 2022, time=2022-02-26, status=1, ipAttribution=)]
    2022-03-28 ms4000001196933191

    这个杂志现在还收稿吗

    0

  10. [GetPortalCommentsPageByObjectIdResponse(id=2122768, encodeId=4ccf2122e6838, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:诊断;消化;肝病<br>经验分享:投稿难度还是比较大的<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=819b5107064, createdName=提奥多拉, createdTime=Thu Mar 30 16:13:17 CST 2023, time=2023-03-30, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2099252, encodeId=839520992525c, content=偏重的研究方向:肝脏疾病;肠道菌群<br>经验分享:中午投稿,晚上状态成Awaiting Reviewer Selection,请问大神这是啥意思?是已经过了编辑那关,准备送外审?还是还在编辑部?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210112/9d391e0b1cd74e869f11d621441146a1/0f85d4b8f25545bc8cd6ff7d737de80d.jpg, createdBy=8aaa108952, createdName=JayNi, createdTime=Tue Nov 08 20:24:51 CST 2022, time=2022-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2101423, encodeId=512e210142384, content=偏重的研究方向:肝病;药物<br>经验分享:今天中午提交的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d0f55424845, createdName=ms7000001723413329, createdTime=Fri Nov 18 22:28:50 CST 2022, time=2022-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1219519, encodeId=594b1219519bd, content=偏重的研究方向:胃肠病;回顾性<br>经验分享:咨询一下,awaiting reviewer selection是什么意思, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9ffb5456603, createdName=ms4000001258378613, createdTime=Sat May 14 09:24:32 CST 2022, time=2022-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1219632, encodeId=c345121963242, content=投稿第二天就成了Awaiting Reviewer Selection状态,连着三天都没有变,是什么情况, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9ffb5456603, createdName=ms4000001258378613, createdTime=Sat May 14 20:03:58 CST 2022, time=2022-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1187960, encodeId=b0b9118e9608c, content=Awaiting Reviewer Selection7天了,IBD的基础研究综述,大家有类似的经历吗?是不是找不到审稿人,还是要被婉拒?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=161, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=62785559987, createdName=ZZLLZZ, createdTime=Tue Jan 25 10:25:06 CST 2022, time=2022-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1207178, encodeId=7ece120e17878, content=大家一般审稿周期多久?投了快20天了,一直是等待审稿人意见。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa635543685, createdName=ms3000001822306968, createdTime=Wed Mar 30 11:26:59 CST 2022, time=2022-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586563, encodeId=05765865636c, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享:12月31投了一篇肝病方向的论著,第二天就显示送外审了,很快,半个月左右就显示Awaiting editor decision应该是外审结果回来了,结果一直等到1月31,正好一个月才给结果,外审送了两个审稿人,提了很多小问题,没说同意也没说拒稿,第三个责任编辑亲自审稿,说杂志只接收13%的文章,不符合杂志内容,建议立即改投他们推荐的杂志,查了一下推荐的杂志,An international journal of gastroenterology and hepatology,连ESCI都不是,最后拒绝了,然后就秒拒了 I?therefore?recommend?that?you?consider?submitting?this?paper?immediately?to?the?journal?GastroHep?(https://onlinelibrary.wiley.com/journal/14781239)?–?a?new?Wiley?journal?in?Gastroenterology?and?Hepatology. To?transfer?your?article?and?the?associated?reviews?to?the?GastroHep?ScholarOne?submission?website,?please?click?the?link?below.??A?member?of?the?GastroHep?editorial?office?will?then?be?in?touch. Accept?transfer: ***?PLEASE?NOTE:?This?is?a?two-step?process.?After?clicking?on?the?link,?you?will?be?directed?to?a?webpage?to?confirm.?***? https://mc.manuscriptcentral.com/apt?URL_MASK=bf8646654042460592466ce5f6b01cb5, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=312, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2fd62045489, createdName=1861eaa8b6m, createdTime=Sat Mar 14 00:00:00 CST 2020, time=2020-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1206722, encodeId=dec61206e22e1, content=这个杂志现在还收稿吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=154, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ac9d5484204, createdName=ms4000001196933191, createdTime=Mon Mar 28 21:47:21 CST 2022, time=2022-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197549, encodeId=9b12119e549fb, content=这个杂志的审稿速度咋样???一直是awaiting rewiewer comments??? , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=75835552705, createdName=ms1000001073912817, createdTime=Sat Feb 26 18:32:48 CST 2022, time=2022-02-26, status=1, ipAttribution=)]
    2022-02-26 ms1000001073912817

    这个杂志的审稿速度咋样???一直是awaiting rewiewer comments???

    1

    展开1条回复
共71条页码: 1/8页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分